News
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...
A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...
The browser is slated to launch in the coming weeks and aims to use artificial intelligence to fundamentally change how ...
Generative AI exploded onto the scene at the end of 2022, and forever changed our perception – and use – of AI technology. From a predictive model, based on classification and automation, AI shifted ...
Alphabet's core search remains strong, with AI driving engagement, monetization, and enterprise growth at an attractive P/E ...
The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.
Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...
OpenAI is reportedly planning to launch its own web browser in the coming weeks, with an AI-centric approach. Here are the ...
OpenAI’s upcoming AI browser may redefine web use, challenging Google Chrome and shifting billions of queries away from ...
Out to make a bigger difference, Alphabet’s Isomorphic Labs is exploring a much more useful application of AI. The Google ...
Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...
Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine and advance its pipeline.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results